Cancer Related Funding Opportunities

April 2020 Application Deadlines

04/01/2020 - American Cancer Society: Proposals on Role of Health Policy, Insurance in Improving Cancer Prevention Outcomes

Amount/Duration: Up to $200,000 per year for up to 5 years. No indirects
Eligibility: Applicants must be affiliated with a nonprofit institution in the United States, one of its territories, or the Commonwealth of Puerto Rico. Independent investigators at all stages of their career are encouraged to apply.
About: Research on the role of health policy and health insurance in improving access to and the performance of cancer prevention, early detection, and treatment services. Proposals will be accepted for research projects focused on changes in national, state, and/or local policy and the response to those changes by healthcare systems, insurers, payers, communities, practices, and patients.

Application Deadline: April 1, 2020

More Information

For assistance contact:
Development Office – Corporate and Foundation Relations
honour.harlowe@mountsinai.org
646-605-8715

04/06/2020 - The CHEST Foundation: Research Grant in Lung Cancer

Amount/Duration: $60,000 for 1 year. No indirects or salary support
Eligibility: Applicants must be CHEST membership at time of application and licensed physicians. IRB approval must be sought/received for all projects to ensure protection of subjects. Not-for-profit organizations are eligible.
About: Applications must address research that leads to improved medical and/or surgical detection, treatment, and/or cure of lung cancer.

Application Deadline: April 6, 2020

More Information

For assistance contact:
Development Office – Corporate and Foundation Relations
honour.harlowe@mountsinai.org
646-605-8715

04/07/2020 - Pfizer: Patient Education in Chronic Myeloid Leukemia (CML)

Amount/Duration: Up to $200,000 over up to 2 years. 28% indirects
Eligibility: Organizations with a mission related to patient education may apply, including hospitals and medical schools
About: Support will focus on advancing patient education about CML and improving the patient’s ability to make informed decisions about their care.

Application Deadline: April 7, 2020

More Information

For assistance contact:
Development Office – Corporate and Foundation Relations
honour.harlowe@mountsinai.org
646-605-8715

04/13/2020 - Pfizer: Targeted Therapy in Colorectal Cancer

Eligibility: Eligible applicants include entities with a mission related to healthcare professional education and/or healthcare improvement.
About: Support of projects with potential to increase the understanding of targeted therapies, including BRAF inhibitors and their use in the treatment of colorectal cancer (CRC).

Application Deadline: April 13, 2020

More Information

For assistance contact:
Development Office – Corporate and Foundation Relations
honour.harlowe@mountsinai.org
646-605-8715

04/22/2020 - Conquer Cancer – Rising Tide Foundation for Clinical Cancer Research Career Pathway Grants in Symptom Management

Up to six grants will be awarded in 2020: three pairs of grants will go to grant recipients in North America, and three pairs of grants to grant recipients in Europe. Each grant pair includes annual funding for the young physician scientist (must be within the first two years of final training program) and annual funding for a mentor. Each grant may be awarded for a maximum term of up to four years.

Support for Grant Recipient: In the first year, each grant recipient will receive funding of $100,000 through their academic institution as they complete their subspecialty training. Contingent upon approval by Conquer Cancer and RTFCCR, grant recipients may continue to receive funding of $100,000 each year for the next three years to support their research during their early career years as independent faculty.

Support for Mentor: In the first year, each mentor will receive $15,000 as part of the grant to provide support and “protected time” to mentor clinician-scientists at an early career stage in translational, and/or patient-oriented cancer symptom management-focused research. Funding of $15,000 for each mentor for each succeeding year is contingent upon approval by Conquer Cancer and RTFCCR.

Application Deadline: April 22, 2020

More Information

May 2020 Application Deadlines

05/06/2020 - Department of Defense - Lung Cancer Research Program (LCRP) - Idea Development Award

Established Investigators: Independent investigators at or above the level of Assistant Professor (or equivalent); or
New Investigators: Investigators that meet the following criteria by the application submission deadline date:
• Have not previously received a LCRP Idea Development Award or Early Investigator Synergistic Idea Award
• Are within 10 years of first faculty appointment (or equivalent)
• Supports new ideas in the early stages of development representing innovative, high-risk/high-gain research.
• Emphasis on innovation and impact.
• New Investigator category supports applicants early in their faculty appointments or in the process of developing independent research careers.
• Clinical trials not allowed.
• Preliminary data required.
• Relevance to military health strongly encouraged.
• Maximum funding of $350,000 in direct costs (plus indirect costs).
• Period of performance should not exceed 2 years.

Application Deadline: May 6 2020

More Information

05/06/2020 - Department of Defense - Lung Cancer Research Program (LCRP) - Investigator-Initiated Translational Research Award

Independent investigators at or above the level of Assistant Professor (or equivalent)

*Supports translational research that will develop promising ideas in lung cancer into clinical applications. Translational research may be defined as an integration of basic science and clinical observations.
• This mechanism is intended to fund a broad range of translational studies including, but not limited to, the following:
• Studies advancing/translating in vitro and/or animal studies to applications with human samples/cohorts
• Late-stage preclinical work leading to/preparing for a clinical trial, e.g., Investigational New Drug submission
• Correlative studies that are associated with an ongoing or completed clinical trial and projects that develop endpoints for clinical trials
• Preliminary data required.
• Relevance to military health strongly encouraged.
• Maximum funding of $400,000 in direct costs (plus indirect costs).
• Period of performance should not exceed 2 years.

Application Deadline: May 6 2020

More Information

05/27/2020 - Department of Defense - Lung Cancer Research Program (LCRP) - Concept Award

Investigators at all academic levels
• Supports highly innovative, untested, potentially groundbreaking concepts in lung cancer.
• Emphasis on innovation.
• Clinical trials not allowed.
• Preliminary data discouraged.
• Relevance to military health strongly encouraged.
• Maximum funding of $100,000 in direct costs (plus indirect costs).
• Period of performance should not exceed 1 year.

Application Deadline: May 27, 2020

More Information

July 2020 Application Deadlines

07/01/2020 - Damon Runyon-Rachleff Innovation Award Stage 1

Amount/Duration: $200,000 per year for up to 4 years. No indirects
Eligibility: Applicants (including non-U.S. citizens) must be conducting independent research at a U.S. research institution and have received an MD, DO, PhD, or MD/PhD degree(s) from an accredited institution.
About: Award is designed to provide support for the next generation of exceptionally creative thinkers with “high-risk/high-reward” ideas that have the potential to significantly impact our understanding of and/or approaches to the prevention, diagnosis or treatment of cancer.

Application Deadline: April 01, 2020

More Information

For assistance contact:
Development Office – Corporate and Foundation Relations
honour.harlowe@mountsinai.org
646-605-8715

07/01/2020 - The Hope Foundation for Cancer Research: SWOG/Hope Foundation Impact Award

Amount/Duration: up to $250,000 over 2 years. Up to 25% indirects
Eligibility: Any SWOG member investigator eligible for NIH funding is encouraged to submit to this program. Awardees are expected to present their work at one or more semiannual SWOG group meetings and to adhere to Group policies and procedures as applicable to the project.
About: Encourages innovative SWOG research by supporting early and conceptual stages of these projects. The work proposed should use resources from completed SWOG trials or be directly translatable to clinical trials in SWOG and the NCTN in the foreseeable future.

Application Deadline: July 01, 2020

More Information

For assistance contact:
Development Office – Corporate and Foundation Relations
honour.harlowe@mountsinai.org
646-605-8715

GCO Funding Opportunities

Monthly and continuous submission funding opportunity packets are available on the GCO Funding Opportunities web page.

STAY CONNECTED

Sign up for the Research Listserv to stay up to date with the latest news and events.